Frédéric is a partner in the firm's Intellectual Property practice in Paris specialising in cross-border litigation, including the related regulatory aspects in the pharmaceutical field. He has developed particularly strong expertise in the life sciences and TMT fields, being involved in a number of major and high value patent cases for leading innovator pharmaceutical companies and leading TMT actors.
Frédéric’s practice notably focuses on representing pharmaceutical innovators and high-tech companies in cross-border patent litigation involving numerous jurisdictions. He also has extensive experience in both advising and acting in Intellectual Property disputes in France, including for trademark and copyright related advice and disputes.
Frédéric’s experience includes advising:
Major international pharmaceutical companies on the enforcement of patent and SPC rights on antibodies, small molecules, and second medical use claims, including in preliminary injunction and provisional damages proceedings
International companies on the remuneration of their employee inventors and assignment of inventions
Major oil companies on the enforcement of their Intellectual Property rights
Major French and foreign smartphone and networks providers on the pan-European enforcement of their Intellectual Property rights, including their copyright, models and standard essential patents (FRAND).
Prior to joining Herbert Smith Freehills, Frédéric was counsel in the IP department of an international law firm in Paris.